ClosedBusiness

Medical Research Future Fund – Congenital Heart Disease

Australian Government · Australia

The Congenital Heart Disease grant opportunity provides funding of up to $10 million for research to develop new diagnoses and treatment options for congenital heart disease. A total of $20 million is available over 5 years, with grants covering up to 100% of eligible project costs. Projects must be completed by 30 June 2024.

Official Grant Page

Funding

Up to $10M

Closed

30 June 2024

Duration

up to 5 years, with projects completed by 2024-06-30

Location

Australia

Who Can Apply

Intended for researchers conducting congenital heart disease research. Projects should ideally align with the National Strategic Action Plan for Childhood Heart Disease. Research must complement, and not duplicate, existing MRFF Accelerated Research investments in related CHD studies. Projects must be completed by 30 June 2024, with grants up to $10 million and up to 100% of eligible costs.
This grant opportunity is intended for researchers undertaking projects that provide new diagnoses and treatment options for people with congenital heart disease. Ideally, projects should align with the National Strategic Action Plan for Childhood Heart Disease and target research priorities such as preventing neurodevelopmental and mental health complications, understanding the impact of prenatal and postnatal factors on the health of children born with CHD and their families, and exploring the role of exercise and increased activity in reducing the impact of CHD. New research must be complementary to, and not duplicate, existing Medical Research Future Fund Accelerated Research investments, including the Stem Cells Australia study into development of human heart tissue and the Murdoch Children’s Research Institute project extending the Cardiovascular Genetic Disorders Flagship study. There is no minimum grant amount, the maximum grant amount is $10 million, and grants can cover up to 100% of eligible project costs. A total of $20 million is available over 5 years and projects must be completed by 30 June 2024. The grant opportunity is currently closed to applications.

What's Funded

Medical and health research projects that develop new diagnostic methods and treatment options for congenital heart disease, including studies on neurodevelopmental and mental health complications, prenatal and postnatal factors affecting children with CHD and their families, and the role of exercise and increased activity in reducing the impact of CHD.

Expected Outcomes

New or improved diagnostic tools and treatment options for congenital heart disease, better understanding of neurodevelopmental and mental health complications, evidence on the impact of prenatal and postnatal factors on children with CHD and their families, and research findings on how exercise and increased activity can reduce the impact of CHD.

Key Information

Applicant Types

universitynon_profitcompanyother

Stage

any

Funding Purposes

researchr_and_dinnovationother

Keywords

Medical Research Future FundMRFFcongenital heart diseasechildhood heart diseasecardiovascularhealth researchmedical researchdiagnosis

Frequently Asked Questions

What is the Medical Research Future Fund – Congenital Heart Disease?

The Medical Research Future Fund – Congenital Heart Disease is a business grant offered by Australian Government in Australia, providing Up to $10M in funding. The Congenital Heart Disease grant opportunity provides funding of up to $10 million for research to develop new diagnoses and treatment options for congenital heart disease. A total of $20 million is available over 5 years, with grants covering up to 100% of eligible project costs. Projects must be completed by 30 June 2024.

How much funding does the Medical Research Future Fund – Congenital Heart Disease provide?

The Medical Research Future Fund – Congenital Heart Disease provides Up to $10M in funding. The typical project duration is up to 5 years, with projects completed by 2024-06-30.

Who is eligible for the Medical Research Future Fund – Congenital Heart Disease?

Intended for researchers conducting congenital heart disease research. Projects should ideally align with the National Strategic Action Plan for Childhood Heart Disease. Research must complement, and not duplicate, existing MRFF Accelerated Research investments in related CHD studies. Projects must be completed by 30 June 2024, with grants up to $10 million and up to 100% of eligible costs.

When does the Medical Research Future Fund – Congenital Heart Disease close?

Applications closed on 30 June 2024.

What activities are funded?

Medical and health research projects that develop new diagnostic methods and treatment options for congenital heart disease, including studies on neurodevelopmental and mental health complications, prenatal and postnatal factors affecting children with CHD and their families, and the role of exercise and increased activity in reducing the impact of CHD.

How do I apply for the Medical Research Future Fund – Congenital Heart Disease?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.

Start with Beta DocsBook a free consultation